The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 39 (2), 150-154
- https://doi.org/10.1016/0026-0495(90)90068-n
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Familial hypercholesterolemia and apolipoprotein E4Atherosclerosis, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in JapanAtherosclerosis, 1988
- Association of the apolipoprotein E4 allele with hypercholesterolemia in apparently healthy male adults in TokyoJournal of Human Genetics, 1987
- Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Effects of apoprotein E polymorphism on serum lipoprotein concentration.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.JCI Insight, 1984
- Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patientEuropean Journal of Clinical Investigation, 1984
- Identical Structural and Receptor Binding Defects in Apolipoprotein E2 in Hypo-, Normo-, and Hypercholesterolemic DysbetalipoproteinemiaJCI Insight, 1983